Endokrine Orbitopathie

详细信息    查看全文

• 作者：Prof. Dr. I. Strempel
• 关键词：Graves’ disease ; Stress ; Depression ; Exophthalmus ; Psychotherapie ; Graves’ disease ; Stress ; Exophthalmos ; Psychotherapy ; Depression
• 刊名：Der Ophthalmologe
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：113
• 期：2
• 页码：126-130
• 全文大小：328 KB
• 参考文献：1.Bang Bové K, Watt T, Vogel A et al (2014) Anxiety and depression are more prevalent in patients with Graves’disease than in patients with nodular goitre. Eur Thyroid J 3:173–178CrossRef
  2.Basińska MA, Merc M, Juraniec O (2009) Mood of individuals with Graves-Basedow’s disease and Hashimoto’s disease. Endokrynol Pol 60(6):461–468PubMed
  3.Belle D (1982) The stress of caring: woman as providers of social support. In: Handbook of stress: theoretical and clinical aspects. Fress Pres, New York S 496–505
  4.Bunevicius R, Velickiene D, Prange AJ Jr (2005) Mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves’disease. Gen Hosp Psychiatry 27(2):133–139CrossRef PubMed
  5.Buschmann W (1992) Endokrine Orbitopathie, Entscheidungen und Ergebnisse. Augenspiegel 11:46–58
  6.Draganić-Gajić S, Lecić-Tosevski D, Svrakić D et al (2008) Psychosomatic concept of hyperthyroidism – Graves type – behavioral and biochemical characteristics. Med Pregl 61(7–8):383–388CrossRef PubMed
  7.Eckstein A, Esser J (2003) Endokrine Orbitopathie. Pathogenese, klinisches Bild Untersuchung, stadienabhängige Therapie. Ophthalmologe 10:857–877CrossRef
  8.Eckstein A, Quadbeck B, Mueller G et al (2003) Impact of smoking on the response to treatment of thyroid associated ophthalmopathy. Br J Ophthalmol 87:773–776PubMedCentral CrossRef PubMed
  9.Eckstein A, Thamos M, Johnson K et al (2009) Wann bekommt man eine endokrine Orbitopathie? Z Prakt Augenheilkd 30:315–326
  10.Farid M, Roch-Levecq AC, Levi L et al (2005) Psychological disturbance in Graves ophthalmopathy. Arch Ophthalmol 123(4):491–496CrossRef PubMed
  11.Fukao A, Takamatsu J, Murakami Y et al (2003) The relationship of psychological factor to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves’disease. Clin Endocrinol (Oxf) 58(5):550–555CrossRef
  12.Jablkowska K, Karbownik-Lewińska M, Nowakowska K et al (2008) Working memory and executive functions in hyperthyroid patients wit Graves’disease. Psychiatr Pol 42(2):249–259PubMed
  13.Kahaly GJ, Petrak F, Hardt J et al (2005) Psychosocial morbidity of Graves’orbitopathy. Clin Endocrinol (Oxf) 63(4):395–402CrossRef
  14.Kung AW (1995) Life events, daily stresses and coping in patients with Graves’disease. Clin Endocrinol (Oxf) 42:303–308CrossRef
  15.Lee H, Roh HS, Yoon JS et al (2010) Assessment of quality of life and depression in Korean patients with Graves’ Ophthalmopathy. Korean J Ophthalmol 24(2):65–72PubMedCentral CrossRef PubMed
  16.Morillio E, Gardner LI (1979) Bereavement as an antecedent factor in thyrotoxiosis of childhood: four case studies with survey of possible metabolic pathways. Psychosom Med 41(7):545–555CrossRef
  17.Pfeilschifter J, Ziegler R (1996) Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption. Clin Endocrinol (Oxf) 45:477–481CrossRef
  18.Placidi GP, Boldrini M, Patronelli A et al (1998) Prevalence of psychiatric disorders in thyroid diseased patients. Neuropsychobiology 38(4):222–225CrossRef PubMed
  19.Ponto KA, Kahaly GJ (2008) Endokrine Orbitopathie – aktuelle Diagnostik und Therapie. Med Klen 103:717–728CrossRef
  20.Ponto KA, Pitz S, Pfeiffer N et al (2009) Endokrine Orbitopathie: Lebensqualität und berufliche Belastung. Dtsch Ärztebl Int 106(17) 283–289PubMedCentral PubMed
  21.Shine B, Fells P, Edwards OM et al (1990) Association between Graves ophthalmopathy and smoking. Lancet 335:1261–1263CrossRef PubMed
  22.Sommer G, Fydrich T (1989) Soziale Unterstützung. Diagnostik, Konzepte, F-SOZU. Deutsche Gesellschaft für Verhaltenstherapie, Tübingen
  23.Steuernagel K (1998) Zum Krankheitsbild der endokrinen Orbitopathie. Inauguraldissertation Marburg
  24.Strempel I, Steuernagel K (1998) Die endokrine Orbitopathie – ein sichtbarer Schrei der Seele? Augenspiegel 7–8:35–40
  25.Uexküll T von (2003) Psychosomatische Medizin, 6. Aufl. Urban & Fischer, Müchen, S 310/1021
  26.Winsa B, Adami HO, Bergstrom R et al (1991) Stressful life events and Graves’disease. Lancet 338:1475–1479CrossRef PubMed
  27.Yoshiuchi K, Kumano H, Nomura S et al (1998) Psychosocial factors influencing the short-term outcome of antithyroid drug therapy in Graves’disease. Psychosom Med 60:592–596CrossRef PubMed
  28.Zeng J, Yan YR, Huang H (2014) Relationship between depression and thyroid hormone levels in patients with Graves disease. Sichuan Da Xue Xue Bao Yi Xue Ban 45(3):460–463, 470PubMed
  29.Zimbardo PG, Gerrig RJ (1996) Psychologie. Springer, Berlin, S 761–766
  
• 作者单位：Prof. Dr. I. Strempel (1)
  
  1. Privatpraxis, In der Augenklinik, UKGM Gießen Marburg, Standort Marburg, Baldingerstraße, 35043, Marburg, Deutschland
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Ophthalmology
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1433-0423

文摘

Background Endocrine orbitopathy (Graves’ disease) is an autoimmune disease based on a genetic predisposition. Patients with a visible exophthalmos were examined and treated in the department of ophthalmology.